A. Gabrielli, E. Avvedimento, T. Krieg, and . Scleroderma, Scleroderma, New England Journal of Medicine, vol.360, issue.19, pp.1989-2003, 2009.
DOI : 10.1056/NEJMra0806188

S. Sato, M. Hasegawa, and K. Takehara, Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis, Journal of Dermatological Science, vol.27, issue.2, pp.140-146, 2001.
DOI : 10.1016/S0923-1811(01)00128-1

A. Koch, L. Kronfeld-harrington, Z. Szekanecz, M. Cho, G. Haines et al., In situ Expression of Cytokines and Cellular Adhesion Molecules in the Skin of Patients with Systemic Sclerosis, Pathobiology, vol.61, issue.5-6, pp.239-246, 1993.
DOI : 10.1159/000163802

B. Needleman, F. Wigley, and R. Stair, Interleukin-1, Interleukin-2, Interleukin-4, Interleukin-6, Tumor Necrosis Factor ??, and Interferon-?? Levels in Sera from Patients With Scleroderma, Arthritis & Rheumatism, vol.135, issue.1, pp.67-72, 1992.
DOI : 10.1002/art.1780350111

E. Scala, S. Pallotta, A. Frezzolini, D. Abeni, C. Barbieri et al., Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement, Clinical and Experimental Immunology, vol.91, issue.3, pp.540-546, 2004.
DOI : 10.1016/S1471-4906(02)00013-3

T. Yamamoto, S. Takagawa, I. Katayama, K. Yamazaki, Y. Hamazaki et al., Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking Scleroderma, Journal of Investigative Dermatology, vol.112, issue.4, pp.456-462, 1999.
DOI : 10.1046/j.1523-1747.1999.00528.x

E. Saito, M. Fujimoto, M. Hasegawa, K. Komura, Y. Hamaguchi et al., CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse, Journal of Clinical Investigation, vol.109, issue.11, pp.1453-1462, 2002.
DOI : 10.1172/JCI0215078

J. Avouac, B. Fürnrohr, M. Tomcik, K. Palumbo, P. Zerr et al., Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis, Arthritis & Rheumatism, vol.78, issue.3, pp.800-809, 2011.
DOI : 10.1002/art.30171

J. Avouac, M. Elhai, M. Tomcik, B. Ruiz, M. Friese et al., Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis, Annals of the Rheumatic Diseases, vol.72, issue.6, pp.1089-1098, 2013.
DOI : 10.1136/annrheumdis-2012-201759

M. Hasegawa, S. Sato, H. Ihn, and K. Takehara, Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis, Rheumatology, vol.38, issue.7, pp.612-617, 1999.
DOI : 10.1093/rheumatology/38.7.612

D. Lauretis, A. Sestini, P. Pantelidis, P. Hoyles, R. Hansell et al., Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis, The Journal of Rheumatology, vol.40, issue.4, pp.435-446, 2013.
DOI : 10.3899/jrheum.120725

Z. Jurisic, D. Martinovic-kaliterna, D. Marasovic-krstulovic, D. Perkovic, L. Tandara et al., Relationship between interleukin-6 and cardiac involvement in systemic sclerosis, Rheumatology, vol.52, issue.7, pp.1298-1302
DOI : 10.1093/rheumatology/ket131

S. Kitaba, H. Murota, M. Terao, H. Azukizawa, F. Terabe et al., Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma, The American Journal of Pathology, vol.180, issue.1, pp.165-176, 2012.
DOI : 10.1016/j.ajpath.2011.09.013

L. Huu, D. Matsushita, T. , J. G. Hamaguchi, Y. Hasegawa et al., IL-6 Blockade Attenuates the Development of Murine Sclerodermatous Chronic Graft-Versus-Host Disease, Journal of Investigative Dermatology, vol.132, issue.12, pp.2752-2761, 2012.
DOI : 10.1038/jid.2012.226

R. Ratsimandresy, E. Duvallet, E. Assier, L. Semerano, L. Delavallee et al., Active immunization against IL-23p19 improves experimental arthritis, Vaccine, vol.29, issue.50, pp.9329-9336, 2011.
DOI : 10.1016/j.vaccine.2011.09.134

S. Bertin-maghit, C. Capini, N. Bessis, J. Chomilier, S. Muller et al., Improvement of collagen-induced arthritis by active immunization against murine IL-1?? peptides designed by molecular modelling, Vaccine, vol.23, issue.33, pp.4228-4235, 2005.
DOI : 10.1016/j.vaccine.2005.03.030

C. Capini, S. Bertin-maghit, N. Bessis, P. Haumont, E. Bernier et al., Active immunization against murine TNF?? peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection, Vaccine, vol.22, issue.23-24, pp.3144-3153, 2004.
DOI : 10.1016/j.vaccine.2004.01.064

J. Wipff, Y. Allanore, and C. Boileau, Interactions between fibrillin-1 and tgf-beta: consequences and human pathology, Med Sci, vol.25, pp.161-167, 2009.

J. Avouac, M. Clemessy, J. Distler, J. Gasc, B. Ruiz et al., Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis, Rheumatology, vol.50, issue.8, pp.1494-1504, 2011.
DOI : 10.1093/rheumatology/keq448

J. Avouac, K. Palumbo, M. Tomcik, P. Zerr, C. Dees et al., Inhibition of activator protein 1 signaling abrogates transforming growth factor ??-mediated activation of fibroblasts and prevents experimental fibrosis, Arthritis & Rheumatism, vol.437, issue.Suppl, pp.1642-1652, 2012.
DOI : 10.1002/art.33501

M. Green, H. Sweet, and L. Bunker, Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton, Am J Pathol, vol.82, pp.493-512, 1976.

N. Takagi, M. Mihara, Y. Moriya, N. Nishimoto, K. Yoshizaki et al., Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis, Arthritis & Rheumatism, vol.41, issue.12, pp.2117-2121, 1998.
DOI : 10.1002/1529-0131(199812)41:12<2117::AID-ART6>3.3.CO;2-G

J. Woessner, . Jr, and R. Boucek, Connective tissue development in subcutaneously implanted polyvinyl sponge, Archives of Biochemistry and Biophysics, vol.93, issue.1, pp.85-94, 1961.
DOI : 10.1016/0003-9861(61)90319-8

J. Wipff, J. Avouac, D. Borderie, D. Zerkak, H. Lemarechal et al., Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin, Rheumatology, vol.47, issue.7, pp.972-975, 2008.
DOI : 10.1093/rheumatology/ken100

Y. Uchiyama, H. Yoshida, N. Koike, N. Hayakawa, A. Sugita et al., Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production, International Immunopharmacology, vol.8, issue.11, pp.1595-1601, 2008.
DOI : 10.1016/j.intimp.2008.07.002

C. Beyer, G. Schett, O. Distler, and J. Distler, Animal models of systemic sclerosis: Prospects and limitations, Arthritis & Rheumatism, vol.47, issue.Suppl 5, pp.2831-2844, 2010.
DOI : 10.1002/art.27647

K. Khan, S. Xu, S. Nihtyanova, E. Derrett-smith, D. Abraham et al., Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis, Annals of the Rheumatic Diseases, vol.71, issue.7, pp.1235-1242, 2012.
DOI : 10.1136/annrheumdis-2011-200955

V. Wallace, S. Kondo, T. Kono, Z. Xing, E. Timms et al., A role for CD4+ T cells in the pathogenesis of skin fibrosis in tight skin mice, European Journal of Immunology, vol.17, issue.6, pp.1463-1466, 1994.
DOI : 10.1002/eji.1830240634

R. Phelps, C. Daian, S. Shibata, R. Fleischmajer, and C. Bona, Induction of Skin Fibrosis and Autoantibodies by Infusion of Immunocompetent Cells from Tight Skin Mice into C57BL/6 Pa/Pa Mice, Journal of Autoimmunity, vol.6, issue.6, pp.701-718, 1993.
DOI : 10.1006/jaut.1993.1059

T. Dodig, K. Mack, D. Cassarino, and S. Clark, Development of the tight-skin phenotype in immune-deficient mice, Arthritis & Rheumatism, vol.81, issue.3, pp.723-727, 2001.
DOI : 10.1002/1529-0131(200103)44:3<723::AID-ANR122>3.0.CO;2-V

R. Ratsimandresy, J. Rappaport, and J. Zagury, Anti-Cytokine Therapeutics: History and Update, Current Pharmaceutical Design, vol.15, issue.17, pp.1998-2025, 2009.
DOI : 10.2174/138161209788453130

URL : http://doi.org/10.2174/138161209788453130